• SANEMUS AG

    We are looking forward to your inquiry!

  • SANEMUS AG

    Your competent partner in the Life Science sector!

About us

SANEMUS AG focuses on investing in company and asset shares in the German healthcare market and offers strategic, financial and merger&acquisition advisory in this context. It was founded in 2006 by experienced healthcare professionals in Munich. The investment focus is exclusively put on the Life Science sector with its submarkets pharmaceutical industry, biotechnology, medical technology, diagnostics and E-health.

Our Mission

We assist to develop commercially attractive companies from promising Start-Ups from the Life Science sector due to the complementary strategic and financial advisory services offered.

We provide strategic input to substantially increase the value of Life Science companies by sophisticated lifecycle und portfolio management as well as strategic partnering.

We advise investors in Life Science investments – either in single investment projects or in Venture Capital or Private Equity Funds – to achieve an individually optimal value increase of their investments.

Current news

SANEMUS wins European VC investors for Exact Imaging

Exact Imaging Inc. (Toronto), a Canadian Medtech Start-Up, successfully closed its Series C Financing Round on December 22nd 2016 at the amount of CAD 21.5 Mio. (15.4 Mio. €). SANEMUS AG was in charge of finding the European investors. Please…

The SANEMUS team supports a second Canadian Start-Up for raising venture capital

The SANEMUS team supports a second Canadian medtech Start-Up for raising venture capital. The Start-Up has developed a non-invasive device to prevent reperfusion injuries caused by ischemia. The team is currently actively searching co-investors…

SANEMUS supports a Canadian medtech Start-Up for the fundraising

Our team supports a Canadian medtech Start-Up for the fundraising. The Start-Up has developed a high-resolution ultrasound technology for the identification of tumor tissue during a prostate biopsy. An European lead-investor could be identified.…

SANEMUS elaborates concept for strategic redirection of a German pharmaceutical company

The SANEMUS team supports a German mid-sized pharmaceutical company for its strategic redirection. The focus lies on the elaboration of strategic options for an expansion of its business to ensure a sustainable growth in the future. Portfolio…
Partners
BVK- Bundesverand Deutscher Kapitalbeteiligungsgesellschaften
Going Public - Das Kapitalmarkt-Portal
Forum MedTech Pharma